Hantz Financial Services’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48K Buy
1,083
+585
+117% +$27.7K ﹤0.01% 1667
2026
Q1
$26K Sell
498
-187
-27% -$13.1K ﹤0.01% 1775
2025
Q4
$63K Buy
685
+452
+194% +$43.2K ﹤0.01% 1339
2025
Q3
$17K Buy
233
+216
+1,271% +$21.9K ﹤0.01% 1629
2025
Q2
$2K Buy
17
+16
+1,600% +$2.32K ﹤0.01% 1990
2025
Q1
$0 Buy
+1
New +$181 ﹤0.01% 1830

Other funds holding INSP

Hantz Financial Services's INSP Position: Q2 2026 in Review

Hantz Financial Services increased its Inspire Medical Systems (INSP) stake by 117% in Q2 2026, buying an estimated $27.7K and bringing the position to 1,083 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Hantz Financial Services first reported a position in INSP in Q1 2025 and has held it in 6 quarters since. The position peaked at $63K in Q4 2025. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Hantz Financial Services held 1,083 shares of Inspire Medical Systems worth $48K as of Q2 2026.
  • Hantz Financial Services bought 585 Inspire Medical Systems shares in Q2 2026, an estimated $27.7K.
  • Inspire Medical Systems made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1667 holding.
  • Hantz Financial Services first reported a position in Inspire Medical Systems in Q1 2025 and has held it in 6 quarters since.
  • Hantz Financial Services's Inspire Medical Systems position peaked at $63K in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.